
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology
Maria Laura Canale, Katia Coviello, G. Solarino, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Maria Laura Canale, Katia Coviello, G. Solarino, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 8
Showing 8 citing articles:
Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα–mTORC1 signaling pathway
Feng Hu, Sen‐bo Yan, Li Lin, et al.
Molecular and Cellular Biochemistry (2024)
Open Access | Times Cited: 2
Feng Hu, Sen‐bo Yan, Li Lin, et al.
Molecular and Cellular Biochemistry (2024)
Open Access | Times Cited: 2
Case Series: Sacubitril/Valsartan Role for Chemotherapy-Induced Cardiotoxicity: An in-Depth Investigation in Saudi Arabia
Abdullah Alshammari, Basmah Qasem, Nouf Almatrafi, et al.
International Medical Case Reports Journal (2024) Vol. Volume 17, pp. 35-41
Open Access | Times Cited: 1
Abdullah Alshammari, Basmah Qasem, Nouf Almatrafi, et al.
International Medical Case Reports Journal (2024) Vol. Volume 17, pp. 35-41
Open Access | Times Cited: 1
Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction
Sena Sert, Emre Karabay, Baris GUNGOR, et al.
Marmara medical journal (2023) Vol. 36, Iss. 1, pp. 99-104
Open Access | Times Cited: 2
Sena Sert, Emre Karabay, Baris GUNGOR, et al.
Marmara medical journal (2023) Vol. 36, Iss. 1, pp. 99-104
Open Access | Times Cited: 2
Sacubitril/valsartan attenuated myocardial inflammation, fibrosis, apoptosis and promoted autophagy in doxorubicin-induced cardiotoxicity mice via regulating the AMPKα-mTORC1 signaling pathway
Feng Hu, Sen‐bo Yan, Li Lin, et al.
Research Square (Research Square) (2024)
Open Access
Feng Hu, Sen‐bo Yan, Li Lin, et al.
Research Square (Research Square) (2024)
Open Access
Cancer treatment-related cardiotoxicity: a focus on sacubitril/valsartan
Feng Hu, Huajiong Yu, Zhaoyang Chen, et al.
Cardiology Plus (2023) Vol. 8, Iss. 3, pp. 149-158
Open Access
Feng Hu, Huajiong Yu, Zhaoyang Chen, et al.
Cardiology Plus (2023) Vol. 8, Iss. 3, pp. 149-158
Open Access
Sacubitril-valsartan: Hope or hype in the battle against cardiotoxicity due to cancer treatment? Authors’ reply
Grzegorz Sławiński, Ewa Lewicka
Kardiologia Polska (2022) Vol. 80, Iss. 9, pp. 960-961
Open Access
Grzegorz Sławiński, Ewa Lewicka
Kardiologia Polska (2022) Vol. 80, Iss. 9, pp. 960-961
Open Access
Cancer treatment-related cardiotoxicity: A focus on sacubitril/valsartan
Feng Hu, Huajiong Yu, Weiping Du, et al.
Authorea (Authorea) (2022)
Open Access
Feng Hu, Huajiong Yu, Weiping Du, et al.
Authorea (Authorea) (2022)
Open Access